Study Details

Back
Study ID 9853-CL-0101
Study Title A Phase 1, Multicenter, Open-Label, Dose Escalation Study of ASP9853 in Combination with Either Docetaxel or Paclitaxel in Subjects with Advanced Non-hematologic Malignancies
Clinicaltrials.gov Identifier NCT01705483
Compound Name ASP9853
Medical Indication or Disease Solid tumors
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 28-Aug-2012
Study Completion Date 11-Jun-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS